This is the promise of microneedle patches (MNP), which are essentially what they sound like. These would also have uses in diagnostics that might one day obliviate the need for drawing blood.

Microneedle patches are the next generation drug delivery technology that will revolutionise the way we administer drugs. The COVID-19 pandemic has changed every aspect of the way we live. It has also ...

The company stated that since its pilot market launch in April 2021, more than 6,000 diabetes patients are now using the device, which comprises a wearable insulin delivery patch for injection ...

The vaccine dose was found to be stable for at least a month at 25 degrees Celsius after being administered as a microneedle 3-D printed patch. This is a clear-cut indicator that the patch shall ...

Switzerland-based CeQur has completed a $120m equity financing round to support the ongoing commercialisation efforts for its CeQur Simplicity insulin delivery device. The company stated that ...

The $50 million Patch Forward Prize, part of BARDA's Project NextGen initiative, aims to accelerate the development and commercialization of microneedle patch technologies for mRNA vaccines ...

The $50 million Patch Forward Prize, part of BARDA's Project NextGen initiative, aims to accelerate the development and commercialization of microneedle patch technologies for mRNA vaccines targeting ...

Patch Forward Prize, established to advance the commercialization of microneedle patch-based mRNA vaccines for COVID-19, seasonal influenza and pandemic influenza. The US$2 million (A$3.2 million ...

LTS' proprietary dissolvable microneedle array patch technology with mRNA vaccines aims for the development of next generation vaccine technologies. Source: LTS LOHMANN Therapie-Systeme AG The Patch ...